Cardioline today
Today Cardioline stands for engineering, development, production and service for solutions addressed to the world of diagnostic cardiology and telemedicine.
Its roots date back to the early ‘60s when the “Cardiolina” was a major player in the market. Generations of physicians in Italy and abroad have chosen the electrocardiograph “Cardiolina” as a partner in their practice.
Since then, Cardioline has sold more than 500,000 units, in more than 60 countries worldwide becoming a synonym for a reliable technology partner for healthcare professionals.
Values
Mission
Cardioline plays a key role in improving global healthcare by technologies and process know-how, bringing the best possible standard of care to every location.
Vision
Cardioline’s goal is to build an accessible, sustainable healthcare system providing physicians with reliable tools to give the most professional medical support available.
Compliance
ISO 13485:2016
Quality management systems for medical devices
ISO 27001
Information Security Management Systems
ISO 9001
Quality management systems
COUNCIL Directive 93/42/EEC
Medical devices and accessories directive
MDR 2017/745
Normative update in progress: all devices under MDR 2017/745
Compliance
ISO 13485:2016
Quality management systems for medical devices
ISO 27001
Initiated the process to obtain the certification ISO 27001 concerning the Information Security Management System
COUNCIL Directive 93/42/EEC
Medical devices and accessories directive
MDR 2017/745
Normative update in progress: all devices under MDR 2017/745
Brian Brenegan
CEO
Joined Cardioline in 2018 as CEO. Worked 28 years with Mortara Instrument, Inc. in a variety of roles, focused on operational management, strategic planning and sales channel management. Graduated with a BBA in Accounting from the University of Wisconsin School of Business (USA).
Fabio Rangoni
President, Co-Founder
More than 30 years of experience in the field of diagnostic cardiology. Was President and CEO of Mortara Europe from 1990-2009 and GM of Mortara Instrument (Milwaukee, WI) from 1992 to 1994. Graduated with degrees in Engineering and Biomedical Technologies from the University of Bologna, later completing training in Marketing and Strategic Management courses at the Bocconi University in Milan.
Sandra Antoniazzi
VP Italian Sales, Co-Founder
Serial entrepreneur, founding Ekar (consulting company, 1992), Crownsquare (real estate services company, 2006) and Elba (insurance company, 2009). President of Arthur D. Little (branch of Altran) in 2000-2006 following the acquisition of Ekar by Altran.
Emanuele Ercoli
CFO/COO
Joined Cardioline in 2012 as Chief Financial Officer. Began his career as an Ekar Controller; was also Administrative Director of Arthur D. Little (subsidiary of Altran) and Financial Director of Altran Italia. Graduated with a degree in Political Economics from the University of Rome "Tor Vergata".
David Lombardi
Director of Research & Development
Joined Cardioline in 2014 as Director of Research and Development. Started with Mortara Instrument in 1998, where he held the position of Software Engineering Manager, doing significant development work in Mortara’s clinical research segment, working on FAA Data Management System and FDA ECG Warehouse. ss Graduated with a degree in Computer Science from the University of Pisa and has over 18 years of experience in the field of diagnostic cardiology.
